1. Home
  2. PLTK vs DBVT Comparison

PLTK vs DBVT Comparison

Compare PLTK & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Playtika Holding Corp.

PLTK

Playtika Holding Corp.

HOLD

Current Price

$3.79

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$19.05

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLTK
DBVT
Founded
2010
2002
Country
Israel
France
Employees
N/A
90
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
PLTK
DBVT
Price
$3.79
$19.05
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$5.04
$32.04
AVG Volume (30 Days)
1.2M
205.9K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
11.46%
N/A
EPS Growth
N/A
10.26
EPS
N/A
N/A
Revenue
$2,755,400,000.00
$5,636,000.00
Revenue This Year
$2.60
$35.04
Revenue Next Year
$2.23
$2,360.78
P/E Ratio
N/A
N/A
Revenue Growth
8.08
35.77
52 Week Low
$2.64
$7.53
52 Week High
$5.05
$26.19

Technical Indicators

Market Signals
Indicator
PLTK
DBVT
Relative Strength Index (RSI) 60.90 47.09
Support Level $3.33 $18.89
Resistance Level $3.81 $21.61
Average True Range (ATR) 0.16 0.78
MACD -0.01 0.00
Stochastic Oscillator 80.39 38.41

Price Performance

Historical Comparison
PLTK
DBVT

About PLTK Playtika Holding Corp.

Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. The company offers both Mobile and Web-based platforms.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: